Figure 8 — An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy

Research Paper|Volume 15, Issue 19|pp. 10453–10472

An immune signature to predict the prognosis of ATRX-wildtype glioma patients and guide immune checkpoint blockade therapy

Back to articleFigure 8(8 of 11)

100%

Figure 8.Construction of the nomogram. (A) Construction of a nomogram using age, sex, grade and risk score. (B) Nomogram in glioma patients with one-, three- and five-year survival.